GMP: EMA issues Draft Guideline on Process Validation for Biotechnological Products - an Analysis

The draft on process validation for biotechnologically manufactured active pharmaceutical ingredients describes the required data to be submitted for the marketing authorisation or variation of biotechnology-derived proteins used as active substance in the manufacture of medicinal products.